Natus Medical Stock Hits New 52-Week Low (BABY)

NEW YORK ( TheStreet) -- Natus Medical (Nasdaq: BABY) hit a new 52-week low Friday as it is currently trading at $10.54, below its previous 52-week low of $10.56 with 71,004 shares traded as of 11:14 a.m. ET. Average volume has been 314,400 shares over the past 30 days.

Natus Medical has a market cap of $317.9 million and is part of the health care sector and health services industry. Shares are down 25% year to date as of the close of trading on Thursday.

Natus Medical Incorporated develops, manufactures, and markets neurodiagnostic and newborn care products worldwide. The company has a P/E ratio of 26.7, above the average health services industry P/E ratio of 21.5 and above the S&P 500 P/E ratio of 17.7.
  • Practice your BABY trading strategies and win cash in our stock game.

TheStreet Ratings rates Natus Medical as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income. You can view the full Natus Medical Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Tiffany & Co. Sees a Strong Market in Asia

Tiffany & Co. Sees a Strong Market in Asia

Stocks Finish Higher After Release of Fed Minutes

Stocks Finish Higher After Release of Fed Minutes